AR2 A COST EFFECTIVENESS ANALYSIS OF INFLIXIMAB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) IN SWEDEN, BASED ON DATA FROM THE STURE REGISTRY
Abstract
Authors
I Lekander F Borgstrm C Carli P Svarvar T Ljung R van Vollenhoven